ABBOTINDIAABBOTINDIA Forensic Risk Analysis

Pharmaceuticals
Risk ClassStable
Market Cap₹53,973 Cr
Primary DriverGovernance
Flagium AI Risk Score
Stable structural profile. Financial profile appears resilient.
0 / 100
0 QoQ
Stable
Sentinel Insight

Financial profile remains stable for now. Pressure has stabilized in governance. This indicates that forensic pressure is currently receding. No major change in risk trend.

0.0th %ile (Sector)Accel: +0 Qtrs
Updated2026-06-02
Market View
₹26,295▼2.03%
PeriodN/A

Score Waterfall
Absolute contribution points of each forensic pillar to the final risk score. Derived from: Sector Baseline + Active Penalties - Mitigation Buffers.

No active forensic penalties contributing.
Final Composite Risk0 / 100

Investment Risk Thesis

Historical Trend

Current risk score has declined from 0 → 0 over 12 quarters.

Expected Direction
⚠ Watch
Primary Deterioration Drivers
  • No active triggers
What to Watch Next Quarter

    Active Risk Objects (0)

    CriticalHigh
    Risk Trajectory
    Historical 12-quarter risk trend (Q-11 to Q0) followed by a 2-quarter predictive funnel (Q+1, Q+2).
    Loading Chart
    Resilience Matrix
    Diagnostic benchmarking comparing structural sensitivity and risk buffers against sector medians.
    MetricValuevs SectorSignal
    Volatility (σ)7.70✅ RESILIENT
    Sensitivity (ε_s)11.00✅ RESILIENT
    Escalation Prob.5%5%✅ NEUTRAL
    Safety Buffer+66.0+47.0✅ RESILIENT
    Forensic Benchmark Context: Pharmaceuticals (n=99 peers)

    Correlation Analysis
    Visualizing the relationship between stock price movement and structural risk objects.

    Loading Chart
    Share Price
    Risk Score (0-100)
    Market Performance
    ₹26,295(-2.03%)
    1M Divergence+1.11%
    1 Week-4.76%
    1 Month+3.38%
    6 Months-8.86%
    1 Year-12.89%
    2 Year+4.48%
    3 Year+25.06%
    Sector Average (1M)+2.27%
    Sentinel Forensic Assessment
    ALGORITHMIC RISK PROFILE • NON-ADVISORY

    The structural architecture is currently robust. Capital resilience buffers in governance remain well-maintained against forensic benchmarks. Systematic scans of structural transparency and audit trails confirm the absence of material structural stress. The current structural trajectory supports a stable risk outlook.

    ABBOTINDIA • MARKET STRUCTURE

    Stage 4 — Declining

    The company is in a defensive phase. Sentiment and fundamentals are deteriorating under persistent downward pressure, indicating elevated risk levels.

    Stage Transition Prob.0%
    Trend QualityDeteriorating
    Phase Progression
    Phase Progression Score0%
    Readiness LabelLow (Early Base Consolidation)
    Probability of Advancing0%
    CoinTree Momentum
    Composite Z-Score-0.3943σ
    Weakening momentum trend
    Universe Rank
    A cross-sectional rank of this stock's composite momentum score compared to all other tracked equities in the universe. A rank of #1 of 1035 means it has the strongest overall price momentum in the market.
    #1868 of 2716
    Top 68.78% in momentum strength
    Timeframe Sparklines
    1W-4.8%
    1M+3.4%
    6M-8.9%
    Weinstein Indicators
    150 DMA₹27,553.03
    200 DMA₹28,423.78
    150 DMA Slope-1.2970%Declining
    Relative Strength-3.37%Lagging
    Relative Turnover (RTR)1.4553
    ParticipationHealthy

    PEER COMPARISON

    Ranked comparison against sector peers

    This company appears relatively stable compared to the Sector Mean (19).
    ABBOTINDIAABBOTINDIA
    0 Risk
    Sector %ile0th
    Delta0
    Active Flags0
    Accel+0
    Governance

    Stable

    ACUTAASAcutaas Chemicals Limited
    0 Risk
    Sector %ile0th
    Delta0
    Active Flags8
    Accel+0
    Governance

    Stable

    AARTIDRUGSAarti Drugs Limited
    19 Risk
    Sector %ile51th
    Delta-5
    Active Flags11
    Accel+0
    Competitive Position

    Stable

    AAREYDRUGSAarey Drugs & Pharmaceuticals Limited
    23 Risk
    Sector %ile63th
    Delta-5
    Active Flags20
    Accel+0
    Balance Sheet Stress

    Watch

    * Peer comparison is based on risk signals, not valuation or returns.

    Risk Profiles

    Solvency
    10100th %ile
    VS Sector Median (8.5)
    Governance
    10100th %ile
    VS Sector Median (8.5)
    Earnings Quality
    10100th %ile
    VS Sector Median (8.5)
    Balance Sheet Stress
    10100th %ile
    VS Sector Median (8.5)
    Competitive Position
    10100th %ile
    VS Sector Median (8.5)
    Growth Sustainability
    10100th %ile
    VS Sector Median (8.5)

    Deterioration Timeline

    Key Financials (INR Cr)

    PeriodRevenueNet ProfitOCFDebt